Tough competition in the contact lens-care products (CLCP) and ophthalmic surgical products sectors, along with a changing U.S. market for contact lens solutions, are strong factors impacting Advanced Medical Optics' (AMO) debut bank facilities, according to ratings agencies looking at the deal. The $140 million in senior secured bank debt, split between a $40 million, five-year revolver and a six-year, $100 million term loan, has been rated B1 by Moody's Investors Service, while Standard & Poor's views the bank debt a notch higher at BB-. The bank deal, launched last week week by Merrill Lynch and Bank of America, and $175 million in senior subordinated notes, backs the spin-off of AMO from Allergan (LMW, 6/3).
June 09, 2002